Selected category: Corporate
Announcements, Corporate, Healthcare solutions, Gut health, Product, OTC
NEW: The Perenterol® family is growing: Prescribed antibiotics? Perenterol® Protect offers a new yeast-based approach to supporting gut balance during antibiotic therapy.
MEDICE is expanding the Perenterol® brand with a dietary supplement specifically designed to support antibiotic therapies and contribute to the balance of the individual gut microbiota. Perenterol® Protect combines the special yeast strain Saccharomyces boulardii CNCM I-745 with vitamins C and D and is now available.
:focal())
Announcements, Corporate, Healthcare solutions, Gut health
Perenterol® forte und Perenterol® Junior presented in a new design Design
Perenterol® forte and Perenterol® Junior are now available in a new look. The redesigned packaging highlights the proven medicines’ medical quality while creating a consistent brand appearance for the Perenterol® brand with a strong recognition value.
:focal())
Announcements, Corporate, Nephrology, Healthcare solutions
MEDICE Renal Care at the ICRNM 2026 in Berlin
From 15 to 19 September, the XXI. International Congress on Renal Nutrition and Metabolism (ICRNM) will bring together international experts from the fields of kidney health, nutrition and metabolism in Berlin. MEDICE will also be present at the Estrel Congress Centre, Berlin.
:focal())
Announcements, Corporate
MEDICE Health Family Relaunches Urology Website with Expanded Information Offering
The MEDICE Health Family has relaunched its urology website, making it more user-friendly, better tailored to its target audiences, and fully integrated into the central MEDICE Health Family platform.
:focal())
Announcements, Corporate
MEDICE Health Family publishes its sustainability report for the 2025 financial year
The MEDICE Health Family has published its sustainability report for the 2025 financial year.
:focal())
Announcements, Corporate, Nephrology, Healthcare solutions
MEDICE Renal Care at Nephro Update Europe 2026 in Prague
MEDICE will participate in Nephro Update Europe for the second time in 2026. The two-day scientific congress will take place on September 11 and 12, 2026, in Prague and online, providing healthcare professionals with a concise overview of the latest developments in nephrology.
:focal())
Announcements, ADHD, Corporate
MEDICE Health Family as a Gold Sponsor at IACAPAP 2026 in Hamburg
As a Gold Sponsor of IACAPAP 2026, MEDICE Health Family was part of one of the world's leading congresses in child and adolescent psychiatry. More than 2,000 experts from over 100 countries gathered in Hamburg to discuss the latest scientific findings and innovative approaches to improving the mental health of children and adolescents.
:focal())
Announcements, Corporate, Nephrology, Healthcare solutions
ERA 2026 in Glasgow: International Exchange Driving the Future of Nephrology
The ERA Congress 2026 in Glasgow once again underscored its role as one of the leading international platforms for scientific exchange in nephrology. With a record attendance of 10,670 participants, this year's congress brought together experts from academia, clinical practice, and industry from around the world.
:focal())
Announcements, Corporate, Healthcare solutions, Cold, Product, OTC
Launch of Meditonsin Extract: Triple the plant power shortens the duration of a cold
Just in time for the current wave of colds, MEDICE is bringing a herbal cold remedy to pharmacies: Meditonsin Extract. Scientifically proven, it offers a clear advantage—it shortens the duration of the cold.
:focal())
Announcements, Corporate
Handelsblatt award: MEDICE Health Family among the TOP 100 German SMEs for the third time in a row
MEDICE Health Family will once again be among Germany's fastest-growing SMEs in 2025.
:focal())
Announcements, Corporate
Green Guides wins German Sustainability Award
Green Guides, a sustainable subsidiary of the MEDICE Health Family, wins German Sustainability Award.
:focal())
Announcements, Corporate
MEDICE Health Family publishes sustainability report for fiscal year 2024: Significant progress in energy efficiency
MEDICE Health Family publishes sustainability report for fiscal year 2024.
:focal())
Announcements, ADHD, Healthcare solutions, Corporate
attexis® – the first permanently listed DiGA for adults with ADHD
With attexis®, a clinically effective treatment for adults with ADHD is now available and can be prescribed outside the budget restrictions.
:focal())
Corporate
Our Code of Conduct – Living Our Values, Taking Responsibility
The MEDICE Health Family stands for clear values: future-oriented, value-creating and family-oriented. For more than 75 years, our mission has been to care for people. These principles guide our daily actions and our decisions. To embed these values even more firmly in our day-to-day work, we are publishing our Code of Conduct.
:focal())
ADHD, Announcements, Corporate
The MEDICE Health Family acquires Selfapy, one of Germany’s best-known digital health pioneers in the field of mental health disorders.
The MEDICE Health Family acquires Selfapy, one of Germany’s best-known digital health pioneers in the field of mental health disorders.
:focal())
Corporate
Interview: MEDICE Wants to Move Beyond the Pure Pharmaceutical Niche!
The medium-sized pharmaceutical company MEDICE sees itself in the midst of a transformation process from a pure pharmaceutical manufacturer to a provider of healthcare solutions.
:focal())
Corporate
From Pharmaceuticals to Multimodal Healthcare Solutions
For MEDICE, there was reason to celebrate this year. In 2024, the company marked the 75th anniversary of its founding. The family-owned business is now managed by the third generation, which looks back on its roots with great affection.
:focal())
:focal(1284x963:1285x964))